搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按相关度排序
按时间排序
GEN
1 天
Ulcerative Colitis Association with Cancer Risk Linked to p53 Tumor Suppressor Gene
Results provide a mechanistic explanation of why early loss of p53 signaling is frequently observed in UC-associated ...
3 小时
Cancer risk linked to an inflammatory bowel disease: Study reveals
The study emphasises on the role of the p53 tumor suppressor gene in the pathogenesis of ulcerative colitis - an inflammatory bowel disease.
1 天
Eli Lilly's Mirikizumab Shows Long-Term Sustained Efficacy, Safety For Ulcerative Colitis ...
Eli Lilly announced that mirikizumab achieved long-term remission in Phase 3 IBD studies, showing promise for ulcerative ...
ThePrint
2 天
Cancer risk linked to p53 in ulcerative colitis: Study
Researchers in Michael Sigal’s lab at the Max Delbruck Center and Charite – Universitatsmedizin Berlin have discovered the ...
devdiscourse
2 天
Revolutionary Breakthrough: Targeting p53 for Ulcerative Colitis Treatment
New research highlights a pivotal role for the p53 gene in ulcerative colitis progression, offering a potential therapeutic ...
Science Daily
5 天
Cancer risk linked to p53 in ulcerative colitis
Researchers have elucidated the role of the p53 gene in ulcerative colitis. The study suggests a potential new drug target to stop disease progression to cancer.
News Medical on MSN
2 天
P53 Mutation: A Key Player in Cancer Risk for Ulcerative Colitis Patients
Researchers in the lab of Michael Sigal at the Max Delbrück Center and Charité – Universitätsmedizin Berlin have elucidated ...
BioSpace
1 天
Lilly and J&J Face Off in Crohn’s Disease With Phase III Readouts at ACG 2024
Eli Lilly and Johnson & Johnson are seeking label expansions for Omvoh and Tremfya, respectively, in Crohn’s disease ...
The Pharma Letter
1 天
Positive results for Lilly’s mirikizumab in ulcerative colitis and Crohn’s disease
US pharma major Eli Lilly has released results from two, multi-year, Phase III studies that showed patients treated with ...
drugtargetreview.com
1 天
p53’s role in ulcerative colitis and its progression to cancer
The findings offer a promising drug target to prevent progression to colon cancer by targeting abnormal cells early on.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈